Diabetic Foot Ulcers Market is expected to generate a revenue of USD 2.85 Billion by 2028, Globally, at 10.74% CAGR: Verified Market Research®

News provided by

Sep 29, 2022, 10:15 ET

The Diabetic Foot Ulcers Market may be driven by an increase in diabetic foot ulcer patients, a lack of preventive measures, the rising incidence of diabetes, and the world's fast expanding elderly population.

JERSEY CITY, N.J., Sept. 29, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Diabetic Foot Ulcers Market" By Product Type (Advanced Wound Dressings, Skin Substitutes, Growth Factors), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers), and By Geography.

As per the deep research carried out by Verified Market Research, the global Diabetic Foot Ulcers Market was valued at USD 1.27 Billion in 2020 and is projected to reach USD 2.85 Billion by 2028, growing at a CAGR of 10.74% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=10067

Browse in-depth TOC on "Diabetic Foot Ulcers Market"

202 - Pages

126 – Tables

37 – Figures

Global Diabetic Foot Ulcers Market Overview

Diabetes patients frequently develop diabetic foot ulcers, which can result in leg amputation. Diabetes patients who use insulin to manage their condition are at a higher risk of getting a foot ulcer. Additionally, diabetic foot ulcers can occur in persons with obesity, renal, eye, and heart problems, as well as diabetes. Alcohol and tobacco use both increase the risk of the condition. It is a serious complication of diabetes mellitus and is brought on by inflamed or injured feet, nerve damage, poor circulation, and high blood sugar. Diabetes mellitus is one of the metabolic illnesses that impedes the usual phases of wound healing (hyperglycemia).

Over the forecast period, it is anticipated that the global market for diabetic foot ulcers will develop due to the rising incidence of diabetes and its resulting foot ulcers. For instance, 500 million individuals globally had type 2 diabetes in 2018, according to a report by the American Diabetes Association titled "Global Prevalence of Type 2 Diabetes for the Next Ten Years (2018-2028)". Additionally, rising alcohol and cigarette use is anticipated to support market expansion. For instance, 1.337 billion individuals globally smoked tobacco in 2018, according to the World Health Organization. Additionally, over the forecast period, continuous emphasis on avoiding operations and amputations is anticipated to drive the expansion of the global market for diabetic foot ulcers. One of the most significant global public health issues is diabetes mellitus, which increases the chance of developing diabetic foot ulcers.

Key Developments

On November 2020, B. Braun, one of the world's leading manufacturers of medical devices and pharmaceutical products and services, and Grifols, a leading global producer of plasma-derived medicines and provider of technologies and services for hospitals, clinics and compounding centers announced a global partnership to enhance pharmacy production output and therapy safety.
On July 2018, Molnlycke acquired German wound care company SastoMed GmbH, with an aim to expand its product offerings to help patients and healthcare professionals to accelerate the wound healing process.
On December 2019, Orpyx Medical Technologies Inc. launched Orpyx SI Sensory Insoles with remote patient monitoring for the prevention of diabetic foot ulcer.

Key Players

The major players in the market are Acelity L.P. Inc., B. Braun Melsungen AG, BSN Medical GMBH, Coloplast A/S, ConvaTec, Inc., Medline Industries, Inc., Medtronic Plc, Molnlycke Health Care AB, Organogenesis, Inc., and Smith & Nephew Plc.

Verified Market Research has segmented the Global Diabetic Foot Ulcers Market On the basis of Product Type, Ulcer Type, and Geography.

Diabetic Foot Ulcers Market, By Product Type

Advanced Wound Dressings
Skin Substitutes
Growth Factors
Negative Pressure Wound Therapy Devices
Other Devices

Diabetic Foot Ulcers Market, By Ulcer Type

Neuropathic Ulcers
Ischemic Ulcers
Neuro-Ischemic Ulcers

Diabetic Foot Ulcers Market, by Geography

North America

U.S
Canada
Mexico

Europe

Germany
France
U.K
Rest of Europe

Asia Pacific

China
Japan
India
Rest of Asia Pacific

ROW

Middle East & Africa
Latin America

Browse Related Reports:

Diabetic Macular Edema Market By Product (Intravitreal Injections, Intravitreal Implants), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Geography, And Forecast

Diabetic Nephropathy Market By Type (Type 1, Type 2), By Treatment (Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Antioxidant Inflammation Modulator), By Geography, And Forecast

Wound Debridement Market By Product (Gels, Ointments & Creams, Surgical Devices), By Wound (Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers), By Method (Autolytic Methods, Enzymatic Methods), By End User (Hospitals, Clinics), By Geography, And Forecast

Diabetic Neuropathy Drugs Market By Product (Calcium Channel Alpha-2 Delta Ligand, SNRIs and TCAs, Others), By Application (Hospitals, Drug Stores, Others) By Geography, And Forecast

Top 10 Antidiabetics Pharma Companies stopping the silent killer: Sugar rush

Visualize Diabetic Foot Ulcers Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: [email protected]
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

SOURCE Verified Market Research